BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28533679)

  • 1. Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers.
    Kim TE; Ha N; Kim Y; Kim H; Lee JW; Jeon JY; Kim MG
    Drug Des Devel Ther; 2017; 11():1409-1416. PubMed ID: 28533679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Green Tea and (-)-Epigallocatechin Gallate on the Pharmacokinetics of Rosuvastatin.
    Huang S; Xu Q; Liu L; Bian Y; Zhang S; Huang C; Miao L
    Curr Drug Metab; 2020; 21(6):471-478. PubMed ID: 32407265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers.
    Misaka S; Abe O; Sato H; Ono T; Shikama Y; Onoue S; Yabe H; Kimura J
    Eur J Clin Pharmacol; 2018 May; 74(5):601-609. PubMed ID: 29368187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a pharmacokinetic interaction between eslicarbazepine and rosuvastatin: Potential effects on xenobiotic transporters.
    Gidal BE; Mintzer S; Schwab M; Schutz R; Kharidia J; Blum D; Grinnell T; Sunkaraneni S
    Epilepsy Res; 2017 Sep; 135():64-70. PubMed ID: 28624574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.
    Misaka S; Miyazaki N; Fukushima T; Yamada S; Kimura J
    Phytomedicine; 2013 Nov; 20(14):1247-50. PubMed ID: 23920278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interaction between rosuvastatin and telmisartan in healthy Korean male volunteers: a randomized, open-label, two-period, crossover, multiple-dose study.
    Son M; Kim Y; Lee D; Roh H; Son H; Guk J; Jang SB; Nam SY; Park K
    Clin Ther; 2014 Aug; 36(8):1147-58. PubMed ID: 24998012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Black tea extract and theaflavin derivatives affect the pharmacokinetics of rosuvastatin by modulating organic anion transporting polypeptide (OATP) 2B1 activity.
    Kondo A; Narumi K; Okuhara K; Takahashi Y; Furugen A; Kobayashi M; Iseki K
    Biopharm Drug Dispos; 2019 Sep; 40(8):302-306. PubMed ID: 31400238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers.
    Abe O; Ono T; Sato H; Müller F; Ogata H; Miura I; Shikama Y; Yabe H; Onoue S; Fromm MF; Kimura J; Misaka S
    Eur J Clin Pharmacol; 2018 Jun; 74(6):775-783. PubMed ID: 29480324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
    Chow HH; Cai Y; Hakim IA; Crowell JA; Shahi F; Brooks CA; Dorr RT; Hara Y; Alberts DS
    Clin Cancer Res; 2003 Aug; 9(9):3312-9. PubMed ID: 12960117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interaction between rosuvastatin and metformin in healthy Korean male volunteers: a randomized, open-label, 3-period, crossover, multiple-dose study.
    Lee D; Roh H; Son H; Jang SB; Lee S; Nam SY; Park K
    Clin Ther; 2014 Aug; 36(8):1171-81. PubMed ID: 24976448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interaction between rosuvastatin and olmesartan: a randomized, open-label, 3-period, multiple-dose crossover study in healthy Korean male subjects.
    Roh H; Son H; Lee D; Chang H; Yun C; Park K
    Clin Ther; 2014 Aug; 36(8):1159-70. PubMed ID: 25017182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of green tea catechins on the pharmacokinetics of digoxin in humans.
    Kim TE; Shin KH; Park JE; Kim MG; Yun YM; Choi DH; Kwon KJ; Lee J
    Drug Des Devel Ther; 2018; 12():2139-2147. PubMed ID: 30022812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Pharmacokinetics of a Fixed-Dose Combination of Rosuvastatin/Metformin Sustained-Release (10/1000 mg) and Separate Tablets in Healthy Male Subjects.
    Huh KY; Kim E; Lee H; Jeon I; Suh H; Lee J; Lee Y; Yu KS; Lee S
    Clin Pharmacol Drug Dev; 2021 Feb; 10(2):207-213. PubMed ID: 32579298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteers.
    Offman E; Davidson M; Nilsson C
    J Clin Lipidol; 2017; 11(3):739-748. PubMed ID: 28506390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Omeprazole on the Pharmacokinetics of Rosuvastatin in Healthy Male Volunteers.
    Shah Y; Iqbal Z; Ahmad L; Khuda F; Khan A; Khan A; Khan MI; Ismail
    Am J Ther; 2016; 23(6):e1514-e1523. PubMed ID: 25719441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
    Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic drug interaction study using fimasartan and rosuvastatin in healthy volunteers.
    Kang WY; Kim EH; Seong SJ; Gwon MR; Yang DH; Kim HJ; Lim MS; Lee HW; Yoon YR
    Int J Clin Pharmacol Ther; 2016 Dec; 54(12):992-1003. PubMed ID: 27668695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Interactions Between Peficitinib, an Orally Administered, Once-Daily Janus Kinase Inhibitor, and Rosuvastatin in Healthy Subjects.
    Zhu T; Parker B; Wojtkowski T; Nishimura T; Garg JP; Han D; Fisniku O; Keirns J
    Clin Pharmacokinet; 2017 Jul; 56(7):747-757. PubMed ID: 27878567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Green Tea Extract on Atorvastatin Pharmacokinetics in Healthy Volunteers.
    Abdelkawy KS; Abdelaziz RM; Abdelmageed AM; Donia AM; El-Khodary NM
    Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):351-360. PubMed ID: 31997084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of DS-8500a, a Novel G Protein-Coupled Receptor 119 Agonist, on the Pharmacokinetics of Rosuvastatin and Atorvastatin in Healthy Subjects.
    Maekawa Y; Furuie H; Kato M; Myobatake Y; Kamiyama E; Watanabe A; Shiosakai K; Taguchi T; Bass R; Zhou J; Dishy V; Warren V; Vashi V; Ishizuka H
    Clin Drug Investig; 2019 Oct; 39(10):967-978. PubMed ID: 31321631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.